Altogether, our data suggest the presence of cytotoxic c-Met+ CD8+ clones derived from cancer patients, and these cells have a higher cytotoxic capacity compared to c-Met− CD8+ clones, which is decreased upon in vitro treatment with HGF. This evidence concerns the gene MET and cancer.